BioInvent International Aktiebolag
556537-7263ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Yleiskatsaus
- 100–199
- Työntekijät
- 20–50milj SEK
- Liikevaihto
- 1997
- Perustettu
Avainpäättäjät
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
+19 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556537726301
Päättäjät
23 yhteystietoa FunnelfeedrissäCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Björn Frendéus
CSO
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Vincent Ossipow
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Muut yhteyshenkilöt
Marina Mangold
Data Protection Officer
Mona Welschof
Clinical Operations
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäAlligator Bioscience AB
10–19 työntekijätClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 työntekijätDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 työntekijätDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Selaa lisää
Kysymyksiä yrityksestä BioInvent International Aktiebolag
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo